摘要
以p-氨基苯乙酸(APA)和六亚甲基二异氰酸酯(HDI)为连接基团,将短链聚乙二醇单甲醚(mPEG)键合到紫杉醇(PTX)上,获得双亲型PTX前药mPEG-APA-PTX和mPEG-HDI-PTX。考察了这两种前药在自主装、体外药物释放动力学、体外细胞毒性和体内血浆清除速率等方面的表现。结果表明:两前药均能在水中自组装形成稳定的纳米颗粒,载药量高达28%;mPEG-HDI-PTX纳米颗粒在水溶液中非常稳定,细胞毒性很弱,在血液系统中清除很快,而mPEG-APA-PTX纳米颗粒在pH=7.4的环境下可缓慢释放出原药PTX,细胞毒性与临床用紫杉醇针剂Tax-ol相当,体内循环时间较Taxol明显延长;mPEG-APA-PTX是一种可自组装、载药量高、体内循环时间长的新型纳米前药。
Two amphiphilic prodrugs, mPEG-APA-PTX and mPEG-HDI-PTX, were prepared by conju- gating PEG monornethyl ether (mPEG) short chains to paclitaxel(PTX) via p-aminophenylacetic (APA) or hexamethylene diisocyanate (HDI) as linkers. The capability of self-assembling, the PTX release kinetics, the cytotoxicity and the life-time in plasma of them were characterized. Results showed that the prodrugs self-assembled into stable nanoparticles in aqueous solution with high drug loading content (280//00). MPEG-HDI-PTX nanoparticles stayed stable in aqueous solution, but completely lost their cytotoxicity and were eliminated rapidly in plasma. While mPEG APA PTX nanoparticles released PTX slowly when pH = 7.4, their cytotoxicity was similar to Taxol and the nanoparticles had a remarkable longer blood cir- culation time than Taxol. In summary, the mPEG-APA-PTX was capable of self-assembly into high drug-loaded and long plasma circulating polymeric nanoparticles.
出处
《功能高分子学报》
CAS
CSCD
北大核心
2013年第2期115-122,共8页
Journal of Functional Polymers